// App-Quantinova.ai

5 : Characterization of potential predictive biomarkers of response to nivolumab in CheckMate-141 in patients with squamous cell carcinoma of the head and neck (SCCHN).

Researchers

Presenter

  • Robert L. Ferris

Principal Investigators

  • George R. Blumenschein

  • Kevin J. Harrington

  • Jerome Fayette

  • A. Dimitrios Colevas

  • Lisa F. Licitra

  • Stefan Kasper

  • Caroline Even

  • Maura L. Gillison

  • Francis Worden

  • Nabil F. Saba

  • Robert I. Haddad

  • Makoto Tahara

  • Yasuhisa Hasegawa

  • Chia-Jui Yen

  • Mark John Lynch

  • Manish Monga

  • William J. Geese

  • Everett E. Vokes

Medical Centers

  • University of Pittsburgh Cancer Institute, Pittsburgh, PA

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • The Institute of Cancer Research & The Royal Marsden, London, Spain

  • University of Lyon, Lyon, France

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Department of Surgery, Westgerman Cancer Center, University Hospital Essen, Essen, Germany

  • Institut Gustave-Roussy, Villejuif, France

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • University of Michigan, Ann Arbor, MI

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • National Cancer Center Hospital, Tokyo, Japan

  • Aichi Cancer Center Hospital, Nagoya, Japan

  • National Cheng Kung University Hospital, Tainan City, Taiwan

  • Bristol-Myers Squibb, Wallingford, CT

  • Mary Babb Randolph Cancer Center (MBRCC), West Virginia University, Morgantown, WV

  • Bristol-Myers Sqiubb, Princeton, NJ

  • The University of Chicago Medical Center, Chicago, IL

Locations

  • United States

  • United Kingdom

  • France

  • Italy

  • Germany

  • Japan

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT02105636

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved